The announcement of a class action lawsuit against Metagenomi, Inc. for alleged securities violations during its IPO period is likely to negatively impact investor sentiment and the stock price in the short term. Legal issues can create uncertainty and potential financial liabilities for the company, leading to a decrease in stock value.